Search Results - "Di Pasqua, Anthony J."

Refine Results
  1. 1

    Tetracycline-Containing MCM-41 Mesoporous Silica Nanoparticles for the Treatment of Escherichia coli by Koneru, Bhuvaneswari, Shi, Yi, Wang, Yu-Chieh, Chavala, Sai H, Miller, Michael L, Holbert, Brittany, Conson, Maricar, Ni, Aiguo, Di Pasqua, Anthony J

    Published in Molecules (Basel, Switzerland) (30-10-2015)
    “…Tetracycline (TC) is a well-known broad spectrum antibiotic, which is effective against many Gram positive and Gram negative bacteria. Controlled release…”
    Get full text
    Journal Article
  2. 2

    3D Printing and Dissolution Testing of Novel Capsule Shells for Use in Delivering Acetaminophen by Gaurkhede, Shantanu G, Osipitan, Ositomiwa O, Dromgoole, Gary, Spencer, Sara A, Pasqua, Anthony J Di, Deng, Jia

    Published in Journal of pharmaceutical sciences (01-12-2021)
    “…Individualized drug delivery improves drug efficacy and safety for patients. To implement individualized drug delivery, patient-specific tailored dosages…”
    Get more information
    Journal Article
  3. 3

    Phenethyl Isothiocyanate and Cisplatin Co-Encapsulated in a Liposomal Nanoparticle for Treatment of Non-Small Cell Lung Cancer by Sun, Mengwei, Shi, Yi, Dang, Utkarsh J, Di Pasqua, Anthony J

    Published in Molecules (Basel, Switzerland) (22-02-2019)
    “…Lung cancer is the leading cause of cancer-related death in the Unites States, and approximately 85% of all lung cancers are classified as non-small cell lung…”
    Get full text
    Journal Article
  4. 4

    Preparation and Optimization of an Ultraflexible Liposomal Gel for Lidocaine Transdermal Delivery by Sun, Mengwei, Osipitan, Ositomiwa O, Sulicz, Ewa K, Di Pasqua, Anthony J

    Published in Materials (14-07-2022)
    “…The pain caused by lidocaine injections into the face prior to facial plastic surgeries intended to remove growths or tumorous lesions has been reported by…”
    Get full text
    Journal Article
  5. 5

    Physicochemical Factors That Influence the Biocompatibility of Cationic Liposomes and Their Ability to Deliver DNA to the Nuclei of Ovarian Cancer SK-OV-3 Cells by Sun, Mengwei, Yuan, Yuhao, Lu, Fake, Di Pasqua, Anthony J

    Published in Materials (16-01-2021)
    “…Cationic liposomes composed of 3-[N-(N',N'-dimethylaminoethane)-carbamoyl] cholesterol (DC-chol) and dioleoylphosphatidylethanolamine (DOPE) have previously…”
    Get full text
    Journal Article
  6. 6

    Cytotoxicity of mesoporous silica nanomaterials by Di Pasqua, Anthony J., Sharma, Krishna K., Shi, Yan-Li, Toms, Bonnie B., Ouellette, Wayne, Dabrowiak, James C., Asefa, Tewodros

    Published in Journal of inorganic biochemistry (01-07-2008)
    “…We here measure the toxicity of MCM-41, a mesoporous silica nanomaterial, two of its functionalized analogs, AP-T, which has grafted aminopropyl groups and…”
    Get full text
    Journal Article
  7. 7

    Phenethyl Isothiocyanate-Containing Carbomer Gel for Use against Squamous Cell Carcinoma by Osipitan, Ositomiwa O, Shi, Yi, Di Pasqua, Anthony J

    Published in Pharmaceutics (15-01-2021)
    “…It is currently estimated that one in every five Americans will develop skin cancer during their lifetime. Squamous cell carcinoma (SCC) is a common type of…”
    Get full text
    Journal Article
  8. 8

    Potassium as a pluripotency-associated element identified through inorganic element profiling in human pluripotent stem cells by Lin, Victor J. T., Zolekar, Ashwini, Shi, Yi, Koneru, Bhuvaneswari, Dimitrijevich, Slobodan, Di Pasqua, Anthony J., Wang, Yu-Chieh

    Published in Scientific reports (10-07-2017)
    “…Despite their well-known function in maintaining normal cell physiology, how inorganic elements are relevant to cellular pluripotency and differentiation in…”
    Get full text
    Journal Article
  9. 9

    A Method for Liposome Co-encapsulation of Phenethyl Isothiocyanate and Cisplatin and Determining Its Toxicity Against Lung and Lung Cancer Cells by Sun, Mengwei, Di Pasqua, Anthony J

    “…Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related deaths in the United States. It is extremely difficult to treat, and its…”
    Get more information
    Journal Article
  10. 10

    Calcipotriol and 5-Fluorouracil Combination Therapy for the Treatment of Actinic Keratosis in the Clinic: A Review Article by Dlott, Anna H., Spencer, Sara A., Di Pasqua, Anthony J.

    Published in Clinical drug investigation (01-10-2024)
    “…This review examines the pharmacology, efficacy and safety, dosage and administration, and place in therapy of the combination of 5-fluorouracil (5-FU) and…”
    Get full text
    Journal Article
  11. 11

    Nitric oxide- and cisplatin-releasing silica nanoparticles for use against non-small cell lung cancer by Munaweera, Imalka, Shi, Yi, Koneru, Bhuvaneswari, Patel, Amit, Dang, Mai H., Di Pasqua, Anthony J., Balkus, Kenneth J.

    Published in Journal of inorganic biochemistry (01-12-2015)
    “…Nitric oxide (NO) and cisplatin releasing wrinkle-structured amine-modified mesoporous silica (AMS) nanoparticles have been developed for the treatment of…”
    Get full text
    Journal Article
  12. 12

    Brigatinib: Novel ALK Inhibitor for Non–Small-Cell Lung Cancer by Spencer, Sara A., Riley, Angela C., Matthew, Adia, Di Pasqua, Anthony J.

    Published in Annals of Pharmacotherapy (01-06-2019)
    “…Objective: We review here the pharmacology, pharmacokinetics, efficacy, safety, dosage and administration, potential drug-drug interactions and place in…”
    Get full text
    Book Review Journal Article
  13. 13

    Chemoradiotherapeutic Magnetic Nanoparticles for Targeted Treatment of Nonsmall Cell Lung Cancer by Munaweera, Imalka, Shi, Yi, Koneru, Bhuvaneswari, Saez, Ruben, Aliev, Ali, Di Pasqua, Anthony J, Balkus, Kenneth J

    Published in Molecular pharmaceutics (05-10-2015)
    “…Lung cancer is the leading cause of cancer-related death in the United States and approximately 85% of all lung cancers are classified as nonsmall cell…”
    Get full text
    Journal Article
  14. 14

    Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery by Sun, Mengwei, Dang, Utkarsh J., Yuan, Yuhao, Psaras, Alexandra Maria, Osipitan, Ositomiwa, Brooks, Tracy A., Lu, Fake, Di Pasqua, Anthony J.

    Published in AAPS PharmSciTech (09-05-2022)
    “…Lipid nanoparticles (LNPs) can be used as delivery vehicles for nucleic acid biotherapeutics. In fact, LNPs are currently being used in the Pfizer/BioNTech and…”
    Get full text
    Journal Article
  15. 15

    Tirbanibulin: Topical Treatment for Actinic Keratosis by Dlott, Anna H., Di Pasqua, Anthony J., Spencer, Sara A.

    Published in Clinical drug investigation (01-09-2021)
    “…We review here the pharmacology, pharmacokinetics, efficacy, dosage and administration, and place in therapy of tirbanibulin for the treatment of actinic…”
    Get full text
    Journal Article
  16. 16

    Proteins as binding targets of isothiocyanates in cancer prevention by Mi, Lixin, Di Pasqua, Anthony J., Chung, Fung-Lung

    Published in Carcinogenesis (New York) (01-10-2011)
    “…Isothiocyanates are versatile cancer-preventive compounds. Evidence from animal studies indicates that the anticarcinogenic activities of ITCs involve all the…”
    Get full text
    Journal Article
  17. 17

    Radiotherapeutic Bandage Based on Electrospun Polyacrylonitrile Containing Holmium-166 Iron Garnet Nanoparticles for the Treatment of Skin Cancer by Munaweera, Imalka, Levesque-Bishop, Daniel, Shi, Yi, Di Pasqua, Anthony J, Balkus, Kenneth J

    Published in ACS applied materials & interfaces (24-12-2014)
    “…Radiation therapy is used as a primary treatment for inoperable tumors and in patients that cannot or will not undergo surgery. Radioactive holmium-166 (166Ho)…”
    Get full text
    Journal Article
  18. 18

    Biocompatibility of Mesoporous Silica Nanoparticles? by Shi, Yi, Miller, Michael L., Di Pasqua, Anthony J.

    “…Mesoporous silica nanoparticles (MSNs) have been widely explored as drug delivery vehicles in cell and animal studies. To move this nanoparticle platform into…”
    Get full text
    Journal Article
  19. 19

    Neutron-activatable holmium-containing mesoporous silica nanoparticles as a potential radionuclide therapeutic agent for ovarian cancer by Di Pasqua, Anthony J, Yuan, Hong, Chung, Younjee, Kim, Jin-Ki, Huckle, James E, Li, Chenxi, Sadgrove, Matthew, Tran, Thanh Huyen, Jay, Michael, Lu, Xiuling

    Published in Journal of Nuclear Medicine (01-01-2013)
    “…Mesoporous silica nanoparticles (MSNs) were explored as a carrier material for the stable isotope (165)Ho and, after neutron capture, its subsequent…”
    Get full text
    Journal Article
  20. 20

    Laminated holmium-166-containing electrospun bandages for use against skin cancer by Osipitan, Ositomiwa O., Sun, Mengwei, Gordish-Dressman, Heather, Wendt, Richard, Wight-Carter, Mary, Balkus, Kenneth J., Di Pasqua, Anthony J.

    Published in Nuclear medicine and biology (01-11-2022)
    “…The number of non-melanoma skin cancer (NMSC) cases in the US will increase significantly over the next decade due to a rise in UV exposure. One of the…”
    Get full text
    Journal Article